---
title: "Entero Therapeutics (ENTO.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ENTO.US.md"
symbol: "ENTO.US"
name: "Entero Therapeutics"
industry: "Biotechnology"
---

# Entero Therapeutics (ENTO.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |

## Company Profile

Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge an...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.40 | - | - | - | - |
| PB | -1.12 | - | 0.32 | 0.30 | 0.27 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.99 |
| Highest Target | 108.00 |
| Lowest Target | 108.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/ENTO.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ENTO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ENTO.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.